How heart rate affects heart pumping strength in people with heart failure and diabetes
Official title: The Force Frequency Relationship in Heart Failure: an Expression of a Metabolic Problem Driving Adverse Remodelling?
Run by University of Leeds · NCT07309523 · Data updated 2026-11-12
Researchers will test whether abnormal metabolism in the heart and skeletal muscle explains why people with heart failure, especially those with diabetes, do not increase heart pumping effectively when their heart rate rises.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 160 (estimated) |
| Sponsor | University of Leeds Academic / other |
| Drugs / interventions | radiation |
| Locations | 1 site (Leeds, West Yorkshire) |
| Status | Recruiting |
| Started | September 1, 2024 |
| Main results expected | August 30, 2034 |
| Study ends | August 30, 2034 |
| Registry record updated | January 5, 2026 |
| Trial ID | NCT07309523 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (>18 years) who have a guideline-based indication for pacemaker or defibrillator implantation, can give informed consent, and are able to attend implantation and follow-up visits are eligible, including those with heart failure with or without diabetes.
✕Probably not a fit
People who do not need a device implant, those with acute infections, acute ischemia, severe kidney or liver failure, significant anemia, pregnancy, or other listed exclusions are unlikely to benefit from or be eligible for this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study will recruit patients undergoing pacemaker or defibrillator implantation and take small samples of fat and muscle from the operation site, with thigh muscle taken in a subgroup, plus blood samples from coronary, peripheral venous, and arterial sites during different paced heart rates and modes. Coded tissue and blood samples will be stored for metabolomic analysis to identify metabolic pathways linked to an abnormal force–frequency relationship (FFR). Patients will be followed for six months with cardiac ultrasound and non-invasive cardiac monitoring to chart left ventricular FFR and clinical progression. The goal is to link cardiac and peripheral metabolic changes, and the influence of diabetes, to abnormalities in how the heart increases contraction with higher rates.
Why it matters
Potential benefit: If successful, the work could identify metabolic targets that lead to new ways to improve heart performance in people with heart failure and those with diabetes.
How similar studies have gone: Prior research has linked metabolic abnormalities to heart failure, but this specific approach combining intraoperative tissue and multi-site blood sampling with paced FFR measurements is relatively novel and not yet proven.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Guideline-compliant, clinical indication for pacemaker implantation * Age \>18 years * Ability to provide written informed consent * Persons who are legally competent and mentally able to follow the instructions of the study staff Exclusion Criteria: * Anemia Hb \<8 mg/dl * Patients with acute infectious diseases (e.g. pneumonia) * Patients with heart failure due to sepsis * People with acute myocardial ischemia, which is manifested, for example, by angina pectoris or ECG changes under stress * Patients with acute liver or kidney failure * Pregnant and breastfeeding women * People who are institutionalized on official or court orders * People who are dependent or employed by the sponsor or investigator * Taking study medication (of an investigational drug) 30 days before the start of the study * Known contrast allergy or eGFR \<20ml/min/1.73m2 * Pregnancy not excluded by bedside pregnancy test in premenopausal women
Where it's running
-
Leeds Teaching Hospitals NHS Trust
Leeds, West Yorkshire, United Kingdom Recruiting
Study contacts
- Study coordinator: Klaus K Witte, MD
- Email: k.k.witte@leeds.ac.uk
- Phone: 00441133926642
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
-
Continuous temperature monitoring of the feet with connected insoles and a smartphone app in adults with diabetes at high risk
This trial tests whether the Solsius SelfCare system can reliably flag pre-ulcer foot changes in adults with diabetes by detecting temperature differences between feet for at least two consecutive days.
-
RIGHTEST iFree 2 CGM system for better diabetes control in adults on insulin
A real-time CGM system is tested to see if it improves blood sugar control for adults with type 1 or type 2 diabetes on insulin, compared with finger-stick monitoring.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.